INKT MiNK Therapeutics, Inc.
Healthcare$10.44-3.96%ClosedMarket Cap: $52.0M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$35.00
Target (Median)
$35.00
Target Range
$35.00 - $35.00
Upside from current price: 235.2%
Rating Distribution
0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-18 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-01 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-08-15 | HC Wainwright & Co. | upgrade | Buy | Neutral |
| 2025-07-15 | HC Wainwright & Co. | downgrade | Neutral | Buy |
| 2025-07-14 | William Blair | downgrade | Market Perform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-3.61 | $125.0K | 1 |
| Fri Dec 31 | $-2.86 | $4.4M | 2 |
| Sun Dec 31 | $-3.49 | $1.9M | 2 |
| Mon Dec 31 | $-2.84 | $27.9M | 1 |